Cybin Corp. Announces Reverse Take-Over Transaction and the Engagement of Stifel GMP and Eight Capital to Co-Lead Concurent Private Placement of up to $21M Psychedelics Investing
Numinus Receives Health Canada Licence Amendment To Produce And Extract Psilocybin From Mushrooms Pharmaceutical Investing
Codebase Ventures Inc Updates Its World High Life Investment as Love Hemp Appoints Chief Scientific & Regulatory Advisor Cannabis Investing News
Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program Pharmaceutical Investing
